Ladenburg Thalmann Financial Services’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$49K Buy
1,200
+500
+71% +$19.8K ﹤0.01% 3550
2019
Q3
$25K Buy
700
+300
+75% +$12.2K ﹤0.01% 3904
2019
Q2
$21K Hold
400
﹤0.01% 4028
2019
Q1
$23K Buy
400
+100
+33% +$4.95K ﹤0.01% 3916
2018
Q4
$13K Buy
300
+200
+200% +$11.7K ﹤0.01% 4134
2018
Q3
$8K Buy
+100
New +$7.21K ﹤0.01% 4398
2018
Q1
Sell
-154
Closed -$5K 5178
2017
Q4
$5K Sell
154
-576
-79% -$17.4K ﹤0.01% 4528
2017
Q3
$24K Buy
+730
New +$16.4K ﹤0.01% 3580

Other funds holding RGNX

Ladenburg Thalmann Financial Services's RGNX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Regenxbio (RGNX) stake by 71% in Q4 2019, buying an estimated $19.8K and bringing the position to 1,200 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #3550.

Ladenburg Thalmann Financial Services first reported a position in RGNX in Q3 2017 and has held it in 8 quarters since. 187 funds tracked by Wall St. Rank hold RGNX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,200 shares of Regenxbio worth $49K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 500 Regenxbio shares in Q4 2019, an estimated $19.8K.
  • Regenxbio made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3550 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Regenxbio in Q3 2017 and has held it in 8 quarters since.
  • 187 funds tracked by Wall St. Rank held Regenxbio as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.